AroCell announces patent granted in the US

AroCell announces patent granted in the US

Wednesday, October 17, 2018

Functions of erection-enhancing medicine- These kinds of drugs are used, either alone or in combination, to treat different purchasing viagra in canada cancers. How effective these blue pills are? Well the drugs such as get viagra, and viagra & the component Sildenafil citrate all have result with great outcomes in supporting some men achieve & maintain sufficient amount of time during the sexual intercourse. The reasons might be any for having the sexual tadalafil buy in usa disorders. Stick to your doctor’s recommendations to stay safe and to levitra discount prevent the adverse drug impacts.

AroCell announced that the U.S. Patent and Trademark Office has granted AroCell´s patent US 10,100,128 titled ”Monoclonal Anti-TK1 Antibodies”.

The patent refers to AroCell’s proprietary monoclonal antibodies that enable the specific and sensitive measurement of Thymidine Kinase 1 in blood.

” We are delighted that the U.S. Patent and Trademark Office has granted the US patent. This reinforces our patent position in the U.S. and increases AroCell’s attractiveness as business partner. We will now continue to develop our portfolio of proprietary assets to further expand its business opportunities abroad” says Johan von Heijne.

Source: Company Press Release
Key Fact
News Category :  Intellectual Property
Company: AroCell A
Country Europe > Sweden
North America > United States of America

Leave a Reply

Your email address will not be published. Required fields are marked *

− 2 = 1